Signal2026-07-17
ClinicalTrials.gov

[PHASE2] GLORY: Glofit-GemOx With Liso-Cel For Lymphoma

Part of

Emerging Clinical Immunotherapy And Treatment Trials

Open primary sourceSee the whole picture